Joint symposium on novel cancer therapy by BIOCON and KI at Nobelforum April 25, 2014.

BIOCON, the Medicinal Bioconvergence Research Center (Director Sunghoon Kim) is based at Seoul National University and focuses on novel therapeutic target discovery and validation that can be further explored by the industry.

The 1-day symposium focuses on novel cancer therapy and will be followed by a joint symposium in Seoul, Korea during 2015.

Symposium programme (pdf)

Poster (pdf)